Potency of anidulafungin compared to nine other antifungal agents tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: results from the global SENTRY Antimicrobial Surveillance Program (2008).
about
Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009Identification of an aminothiazole with antifungal activity against intracellular Histoplasma capsulatum.Design, synthesis, and biological evaluation of aminothiazole derivatives against the fungal pathogens Histoplasma capsulatum and Cryptococcus neoformansIn vitro echinocandin susceptibility of Aspergillus isolates from patients enrolled in the Transplant-Associated Infection Surveillance Network.Elevated cell wall chitin in Candida albicans confers echinocandin resistance in vivo.Epidemiology and antifungal resistance in invasive candidiasis.The presence of an FKS mutation rather than MIC is an independent risk factor for failure of echinocandin therapy among patients with invasive candidiasis due to Candida glabrata.Antifungal susceptibility to amphotericin B, fluconazole, voriconazole, and flucytosine in Candida bloodstream isolates from 15 tertiary hospitals in Korea.Anidulafungin: is it a promising option in the treatment of pediatric invasive fungal infections?Anidulafungin: when and how? The clinician's view.In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods.Triazole and echinocandin MIC distributions with epidemiological cutoff values for differentiation of wild-type strains from non-wild-type strains of six uncommon species of CandidaFks1 and Fks2 are functionally redundant but differentially regulated in Candida glabrata: implications for echinocandin resistance.Set of classical PCRs for detection of mutations in Candida glabrata FKS genes linked with echinocandin resistance.In vitro activities of anidulafungin and other antifungal agents against biofilms formed by clinical isolates of different Candida and Aspergillus species.Synthesis and biological evaluation of aminothiazoles against Histoplasma capsulatum and Cryptococcus neoformans.
P2860
Q34529179-4744C2E3-DAC1-4C3B-89BD-E4F5285E4AA1Q34788828-C21B6346-2B7A-4FFD-AF03-2D85268D563BQ34996002-9DA424B2-8001-47EB-8DD7-244960E5D748Q35139558-37A351CE-E08E-4373-9B47-3FDCDF172DB0Q35666505-19ADF1EA-464A-48D5-8955-C03FC875A397Q35959495-472BC846-6E01-4137-86CF-CEC2A4F06D25Q36172500-382E2529-7E23-4CD2-A888-C24F789A21D7Q36365036-6356C91C-29E3-4764-AF19-2C2E171366E1Q37854724-2A3B36C9-DC66-42E4-AFED-A1F520B404B7Q37888751-675D1016-8A5A-4CBF-BAD1-27DA139AC6CCQ38725931-69CCDB96-DC9E-44CC-8D0B-5756A250C334Q38956082-0059C1D2-2DC0-4F34-BCC8-11F91C7C5B2BQ41184732-54EF94C4-384D-42A9-864B-7EABF290A28EQ42118113-8D36E818-99A2-4A2B-A213-64BD3FC1B4BEQ42738793-B8E067AD-6B15-4F17-BA28-BD7A74BFFAC4Q52629897-EB85A83A-E134-4926-833E-06EF564DE739
P2860
Potency of anidulafungin compared to nine other antifungal agents tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: results from the global SENTRY Antimicrobial Surveillance Program (2008).
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Potency of anidulafungin compa ...... l Surveillance Program (2008).
@en
type
label
Potency of anidulafungin compa ...... l Surveillance Program (2008).
@en
prefLabel
Potency of anidulafungin compa ...... l Surveillance Program (2008).
@en
P2093
P2860
P356
P1476
Potency of anidulafungin compa ...... l Surveillance Program (2008).
@en
P2093
Gary J Moet
Jeffrey T Kirby
Ronald N Jones
Shawn A Messer
P2860
P304
P356
10.1128/JCM.00328-10
P407
P577
2010-06-09T00:00:00Z